Company / Current Assets per Share
Acadia Pharmaceuticals Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.37
FY2025
5-year range
$3.15 / $6.37
FY2021-FY2025
Trend
+11.8%
vs FY2024
Sector context
#115 of 210
Health Care
What the data says
At $6.37, Acadia Pharmaceuticals's current assets per share ranks #115 of 210 in the Health Care sector. Current Assets per Share has increased for 3 consecutive years, from $3.15 in FY2022 to $6.37 in FY2025.
Based on SEC 10-K filings.
6.37 in FY2025 with a 5-year CAGR of +6.6%.
Improved from $3.80 to $6.37 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +26.4%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
#115 of 210 in Health CareTop 55% of 210This company $6.37 Sector average $134.38
▼
-95.3% below sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 11.8% year-over-year.
- Ranks #115 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.37 | +11.8% |
| FY2024 | $5.70 | +49.9% |
| FY2023 | $3.80 | +20.5% |
| FY2022 | $3.15 | -18.5% |
| FY2021 | $3.87 | -16.3% |
| FY2020 | $4.62 | -12.6% |
| FY2019 | $5.28 | +25.0% |
| FY2018 | $4.23 | +37.4% |
| FY2017 | $3.08 | -42.7% |
| FY2016 | $5.37 | +145.6% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026